FOR OVER 30 YEARS, Quotient has developed and manufactured high quality products for use in transfusion diagnostics. Building on this expertise, in 2010 we received our initial licenses from the
US Food & Drug Administration and commenced selling conventional, liquid reagents in the USA. Quotient also manufactures liquid reagent products to other market leaders in transfusion diagnostics.

We currently have nearly 40 products licensed for sale in the US, with a further 35-40 products in the process of being licensed for commercialization by Quotient or its partners.

Quotient is nearing commercialization of MosaiQ, a next generation automation platform for transfusion diagnostics.

From the News Desk